Insulin-like Growth Factor-1 Receptor Inhibitors [MoA] - N0000193927

Pharmacologic Class Information

Pharmacologic Code N0000193927
Pharmacologic Name Insulin-like Growth Factor-1 Receptor Inhibitors
Pharmacologic Uses
  • insulin-like growth factor-1 receptor inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Insulin-like Growth Factor-1 Receptor Inhibitors

The following table contains 1 products whose active ingredient are classified under the same pharmacologic class Insulin-like Growth Factor-1 Receptor Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
75987-130Tepezza Non-Proprietary Name: TeprotumumabInjection, Powder, Lyophilized, For SolutionIntravenousHorizon Therapeutics Usa, Inc.ACTIVE